[The interferon treatment of chronic hepatitis C. Short- and long-term therapy and the problem of nonresponders].
The interferon therapy has represented a breakthrough in the treatment of chronic hepatitis. In this article we analyzed the results of short- and long-term therapy of hepatitis C, particularly referred to different dosage regimens and side effects. We paid particular attention to patients non responders to interferon therapy, for whom we reported the results obtained with the association of interferon and ursodeoxycholic acid, and with steroidal treatment.
Perasso
A
A
Divisione di Gastroenterologia ed Endoscopia Digestiva, Ospedale San Martino, Genova.
Testino
G
G
D002986:Clinical Trials as Topic; D004306:Dose-Response Relationship, Immunologic; D004351:Drug Resistance; D006526:Hepatitis C / Q000276:immunology / Q000628:therapy*; D006521:Hepatitis, Chronic / Q000276:immunology / Q000628:therapy*; D006801:Humans; D007372:Interferons / Q000009:adverse effects / Q000627:therapeutic use*; D012074:Remission Induction; D013997:Time Factors
D007372:Interferons